Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
Clinical heterogeneity in multiple sclerosis is the rule. Evidence suggests that HLA-DRB1*15 may play a role in clinical outcome. Spinal cord pathology is common and contributes significantly to disability in the disease. The influence of HLA-DRB1*15 on multiple sclerosis spinal cord pathology is un...
Asıl Yazarlar: | DeLuca, G, Alterman, R, Martin, J, Mittal, A, Blundell, S, Bird, S, Beale, H, Hong, L, Esiri, M |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2013
|
Benzer Materyaller
-
The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Yazar:: Yates, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014) -
Spinal cord neuronal pathology in multiple sclerosis.
Yazar:: Gilmore, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009) -
Comment: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis
Yazar:: Yates, R, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions
Yazar:: Evangelou, N, ve diğerleri
Baskı/Yayın Bilgisi: (2005) -
Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
Yazar:: Evangelou, N, ve diğerleri
Baskı/Yayın Bilgisi: (2005)